Suffering from dermatitis? How to find relief this winter
With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.
Medscape1d
European Commission Approves Nemolizumab for Atopic Dermatitis and Prurigo Nodularis
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
Healio1d
Nemluvio approved in EU, UK, Switzerland for atopic dermatitis, prurigo nodularis
Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...
dvm3603d
Treatment options for moderate and severe atopic dermatitis, and when to use what
Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...
Healio3d
Rezpegaldesleukin gets FDA fast track designation for atopic dermatitis
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...
dermatologyadvisor1d
Dupilumab in Atopic Dermatitis: Favorable Cardiometabolic Profile Confirmed
Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
PMLiVE2d
EC approves Galderma’s Nemluvio to treat atopic dermatitis and prurigo nodularis
Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...
The American Journal of Managed Care9d
AI-Enabled Wearable Sensor Reduces Scratching in Atopic Dermatitis
Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...